Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nadroparin Pharmacokinetics in Different Stages of COVID-19-a Prospective Observational Study.

NCT05621915 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT05621915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nadroparin Pharmacokinetics in Different Stages of COVID-19-a Prospective Observational Study.
Lead sponsor
Medical University of Lublin
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
April 15, 2022
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and bleeding disorders, covid-19, mechanical ventilation, nadroparin, thrombosis